Logo image of HSC

HARSCO CORP (HSC) Stock Fundamental Analysis

NYSE:HSC - US4158641070 - Common Stock

9.15 USD
+0.21 (+2.35%)
Last: 6/16/2023, 8:04:00 PM
9.27 USD
+0.12 (+1.31%)
After Hours: 6/16/2023, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, HSC scores 3 out of 10 in our fundamental rating. HSC was compared to 84 industry peers in the Commercial Services & Supplies industry. HSC may be in some trouble as it scores bad on both profitability and health. HSC is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year HSC was profitable.
HSC had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HSC reported negative net income in multiple years.
HSC had a positive operating cash flow in 4 of the past 5 years.
HSC Yearly Net Income VS EBIT VS OCF VS FCFHSC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 200M 400M

1.2 Ratios

HSC has negative profitability rations, so we won't be analyzing them here.
With a Return On Invested Capital value of 2.84%, HSC perfoms like the industry average, outperforming 44.87% of the companies in the same industry.
HSC had an Average Return On Invested Capital over the past 3 years of 2.47%. This is significantly below the industry average of 10.78%.
The 3 year average ROIC (2.47%) for HSC is below the current ROIC(2.84%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 2.84%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.47%
ROIC(5y)3.89%
HSC Yearly ROA, ROE, ROICHSC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 50 -50

1.3 Margins

Looking at the Operating Margin, with a value of 4.29%, HSC is in line with its industry, outperforming 53.85% of the companies in the same industry.
HSC's Operating Margin has declined in the last couple of years.
HSC has a Gross Margin of 18.37%. This is in the lower half of the industry: HSC underperforms 64.10% of its industry peers.
HSC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.29%
PM (TTM) N/A
GM 18.37%
OM growth 3Y-19.83%
OM growth 5Y-16.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.41%
GM growth 5Y-5.58%
HSC Yearly Profit, Operating, Gross MarginsHSC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 20 30

3

2. Health

2.1 Basic Checks

HSC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
HSC has more shares outstanding than it did 1 year ago.
The debt/assets ratio for HSC is higher compared to a year ago.
HSC Yearly Shares OutstandingHSC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
HSC Yearly Total Debt VS Total AssetsHSC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B

2.2 Solvency

An Altman-Z score of 1.84 indicates that HSC is not a great score, but indicates only limited risk for bankruptcy at the moment.
HSC has a Altman-Z score (1.84) which is comparable to the rest of the industry.
The Debt to FCF ratio of HSC is 14.30, which is on the high side as it means it would take HSC, 14.30 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 14.30, HSC is doing good in the industry, outperforming 61.54% of the companies in the same industry.
A Debt/Equity ratio of 2.36 is on the high side and indicates that HSC has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.36, HSC is doing worse than 85.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.36
Debt/FCF 14.3
Altman-Z 1.84
ROIC/WACC0.41
WACC6.98%
HSC Yearly LT Debt VS Equity VS FCFHSC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M 1B

2.3 Liquidity

A Current Ratio of 1.28 indicates that HSC should not have too much problems paying its short term obligations.
With a Current ratio value of 1.28, HSC perfoms like the industry average, outperforming 42.31% of the companies in the same industry.
A Quick Ratio of 1.15 indicates that HSC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.15, HSC is in line with its industry, outperforming 47.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 1.15
HSC Yearly Current Assets VS Current LiabilitesHSC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for HSC have decreased strongly by -98.55% in the last year.
HSC shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -31.51% yearly.
The Revenue has grown by 20.95% in the past year. This is a very strong growth!
HSC shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.64% yearly.
EPS 1Y (TTM)-98.55%
EPS 3Y-54.13%
EPS 5Y-31.51%
EPS Q2Q%-1000%
Revenue 1Y (TTM)20.95%
Revenue growth 3Y7.9%
Revenue growth 5Y7.64%
Sales Q2Q%9.46%

3.2 Future

HSC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.57% yearly.
The Revenue is expected to grow by 4.59% on average over the next years.
EPS Next Y-429.63%
EPS Next 2Y30.33%
EPS Next 3Y47.57%
EPS Next 5YN/A
Revenue Next Year2.58%
Revenue Next 2Y3.39%
Revenue Next 3Y3.57%
Revenue Next 5Y4.59%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HSC Yearly Revenue VS EstimatesHSC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
HSC Yearly EPS VS EstimatesHSC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 915.00, which means the current valuation is very expensive for HSC.
64.10% of the companies in the same industry are cheaper than HSC, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of HSC to the average of the S&P500 Index (27.08), we can say HSC is valued expensively.
Based on the Price/Forward Earnings ratio of 48.97, the valuation of HSC can be described as expensive.
HSC's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of HSC to the average of the S&P500 Index (22.72), we can say HSC is valued expensively.
Industry RankSector Rank
PE 915
Fwd PE 48.97
HSC Price Earnings VS Forward Price EarningsHSC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600 800

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HSC indicates a somewhat cheap valuation: HSC is cheaper than 75.64% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, HSC is valued cheaper than 92.31% of the companies in the same industry.
Industry RankSector Rank
P/FCF 7.66
EV/EBITDA 8.14
HSC Per share dataHSC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as HSC's earnings are expected to grow with 47.57% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.33%
EPS Next 3Y47.57%

0

5. Dividend

5.1 Amount

HSC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

HARSCO CORP

NYSE:HSC (6/16/2023, 8:04:00 PM)

After market: 9.27 +0.12 (+1.31%)

9.15

+0.21 (+2.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-03 2023-05-03/bmo
Earnings (Next)07-31 2023-07-31/bmo
Inst Owners81.44%
Inst Owner Change7.28%
Ins Owners0.37%
Ins Owner Change0%
Market Cap729.61M
Analysts77.5
Price Target13.26 (44.92%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)88.56%
Min EPS beat(2)62.44%
Max EPS beat(2)114.67%
EPS beat(4)4
Avg EPS beat(4)155.96%
Min EPS beat(4)62.44%
Max EPS beat(4)269.74%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)4.21%
Min Revenue beat(2)0.79%
Max Revenue beat(2)7.64%
Revenue beat(4)4
Avg Revenue beat(4)3.05%
Min Revenue beat(4)0.79%
Max Revenue beat(4)7.64%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)2.97%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-347.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.57%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 915
Fwd PE 48.97
P/S 0.38
P/FCF 7.66
P/OCF 3.29
P/B 1.28
P/tB N/A
EV/EBITDA 8.14
EPS(TTM)0.01
EY0.11%
EPS(NY)0.19
Fwd EY2.04%
FCF(TTM)1.19
FCFY13.05%
OCF(TTM)2.78
OCFY30.39%
SpS24.23
BVpS7.14
TBVpS-6.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC 2.84%
ROICexc 2.96%
ROICexgc 6.22%
OM 4.29%
PM (TTM) N/A
GM 18.37%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)2.47%
ROIC(5y)3.89%
ROICexc(3y)2.56%
ROICexc(5y)4.05%
ROICexgc(3y)5.6%
ROICexgc(5y)8.1%
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-19.54%
ROICexcg growth 5Y-18.65%
ROICexc growth 3Y-17.35%
ROICexc growth 5Y-21.85%
OM growth 3Y-19.83%
OM growth 5Y-16.46%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.41%
GM growth 5Y-5.58%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 2.36
Debt/FCF 14.3
Debt/EBITDA 5.55
Cap/Depr 77.78%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.28
Quick Ratio 1.15
Altman-Z 1.84
F-Score4
WACC6.98%
ROIC/WACC0.41
Cap/Depr(3y)84.83%
Cap/Depr(5y)97.73%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-98.55%
EPS 3Y-54.13%
EPS 5Y-31.51%
EPS Q2Q%-1000%
EPS Next Y-429.63%
EPS Next 2Y30.33%
EPS Next 3Y47.57%
EPS Next 5YN/A
Revenue 1Y (TTM)20.95%
Revenue growth 3Y7.9%
Revenue growth 5Y7.64%
Sales Q2Q%9.46%
Revenue Next Year2.58%
Revenue Next 2Y3.39%
Revenue Next 3Y3.57%
Revenue Next 5Y4.59%
EBIT growth 1Y50.18%
EBIT growth 3Y-13.49%
EBIT growth 5Y-10.08%
EBIT Next Year290.02%
EBIT Next 3Y65.64%
EBIT Next 5YN/A
FCF growth 1Y222.26%
FCF growth 3YN/A
FCF growth 5Y-30.03%
OCF growth 1Y426.73%
OCF growth 3YN/A
OCF growth 5Y-3.18%